Mercia Asset Management

Founded 2010

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 10
Rounds per year 0.91
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Health Diagnostics
  • SaaS
  • Medical Device
Summary

The fund is generally included in 2-6 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Video, Health Care. Among the most popular portfolio startups of the fund, we may highlight Sense Biodetection, Voxpopme.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Mercia Asset Management, startups are often financed by Upscale, Mercia Technologies, Mercia Fund Managers. The meaningful sponsors for the fund in investment in the same round are Origin Ventures, NVM Private Equity, Jonathan Milner. In the next rounds fund is usually obtained by Innovate UK.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Health Care
Health Diagnostics
Medical Device
$50M20 Apr 2021 Vale of White Horse, England, United Kingdom

Newcells Biotech

Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Therapeutics
$6M24 Feb 2021 United Kingdom, England

Castings Technology International

Aerospace
$2M21 Jan 2021 United Kingdom, England

StaffCircle

Human Resources
Information Technology
Internet
SaaS
Software
Unified Communications
$917K05 May 2020 United Kingdom, Leicester

CyberOwl

Analytics
Computer
Cyber Security
Internet of Things
Network Security
$2M28 Apr 2020 London, England, United Kingdom

Axis Spine

Health Care
Medical
$1M20 Apr 2020 United Kingdom, England

Gentronix

Biotechnology
Chemical
Cosmetics
$1M20 Jan 2020 United Kingdom, England

Sense Biodetection

Health Care
Health Diagnostics
Medical Device
$14M28 Oct 2019 Vale of White Horse, England, United Kingdom

Voxpopme

Analytics
Enterprise Software
Market Research
SaaS
Video
$9M10 Sep 2019 Salt Lake City, Utah, United States
News
Forensic Analytics Raises £4.5M in Funding

– Forensic Analytics is a digital forensics company based in Letchworth, Hertfordshire, UK.
– The company raised £4.5m in funding.
– The funding was led by Mercia Asset Management PLC via its own balance sheet and the Northern VCT Funds.
– The new investment will be used to further invest into its innovative cloud-based software platform and expand its sales internationally.

Locate Bio Closes £10 Million Funding Round

– Locate Bio is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new investor BGF.
– The funding will be used to further advance Locate Bio’s proprietary pipeline of regenerative orthobiologics products towards patients, with key clinical and regulatory milestones expected to catalyse growth over the next two years.
– The investment brings the total funds raised by Locate Bio to over £18 million. The company’s lead product in development is called LDGraft, and is a low dose, controlled release rhBMP-2 for the treatment of degenerative disc disease.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mercia Asset Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: